In Review: Last year, HB 810 by Representative Rick Jasperese (R) was introduced, establishing NADAC + $10.64 as the reimbursement rate for pharmacies, applying to all plan types except the State Health Benefit Plan and Medicaid. Up Next: House Bill
In Review: Last week, Senator Chuck Hufstetler’s (R) SB 60 was heard in the Senate Insurance Subcommittee. PhRMA spoke in favor of the bill, while PCMA offered our opposition. Ultimately, the committee did not vote on SB 60. Up Next:
In Review: Last week, HB 196 passed out of the House by Representative Trey Kelley (R) and is now awaiting committee assignement in the Senate. House Bill 196 would require the SHBP to reimburse independent pharmacies at NADAC plus the
In Review: Last week, both the House and Senate advanced PBM measures directed at the State Health Benefit Plan (SHBP). HB 196, by Representative Trey Kelly (R), would require the SHBP to reimburse independent pharmacies at NADAC plus the Medicaid
In Review: PCMA is tracking a handful of bills in Georgia, with the two most recent introductions being the most pressing. SB 60 expands the reporting requirements passed in 2020 to include GPOs and drug manufacturer fees to the reporting
In Review: Last week, Senator Kay Kirkpatrick (R) introduced SB 5, which is a gold carding bill. The measure is very similar, if not identical to the gold carding program that Louisiasna adopted 2 yearS ago. Up Next: PCMA anticipates
Up Next: PCMA will participate in a PBM Stakeholder meeting on Monday, October 28. The meeting will be held at the Georgia Capitol and will discuss “PBM practices” that are impacting the Georgia Pharmacy community. PCMA does anticipate PBM legislation
In Review: The Georgia legislature adjourned on Thursday, March 28. PCMA, our member company representatives, and coalition partners successfully defeated all major PBM-related bills. The legislature did pass one bill related to independent pharmacy reimbursement in the State Health Benefit
In Review: Last week in Georgia, SB 198 was gutted and amended to include language that would require the PBM administering the State Health Benefit Plan to reimburse independent pharmacists at the same rate as chains. The bill passed out
In Review: Since the cross-over, PCMA has continued to work in the Senate to amend HB 1363, requiring the State Health Benefit Plan (SHBP) to study the cost implications of moving to a NADAC + reimbursement methodology for pharmacy reimbursement.
